Alessandra D’Addio

Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients

Antonio Curti, Loredana Ruggeri, Alessandra D’Addio et al. · Blood · 2011 · 402 citations · Full text

Life Sciences, Hematology, Immunology +16

Prospective Oral Mucositis Audit: Oral Mucositis in Patients Receiving High-Dose Melphalan or BEAM Conditioning Chemotherapy—European Blood and Marrow Transplantation Mucositis Advisory Group

Nicole Blijlevens, Matthias Schwenkglenks, Pamela Bacon et al. · Journal of Clinical Oncology · 2008 · 193 citations

Dentistry, Oncology, Chemotherapy +16

The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF

Alessandra D’Addio, Antonio Curti, Nina Worel et al. · Bone Marrow Transplantation · 2010 · 88 citations

Medicine, Oncology, Chemotherapy +10

Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient‐specific tumour idiotype protein or idiotype (VDJ)‐derived class I‐restricted peptides

Antonio Curti, Patrizia Tosi, Patrizia Comoli et al. · British Journal of Haematology · 2007 · 67 citations

Medicine, Immunology, Oncology +17

The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT

Shaun R. McCann, Matthias Schwenkglenks, P. Bacon et al. · Bone Marrow Transplantation · 2008 · 60 citations

Dentistry, Oral Medicine, Oral Oncology +13